Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Realistic Productivity in Academic Neuroradiology: A National Survey of Neuroradiology Division Chiefs.

AJNR. American journal of neuroradiology·2023
Same author

'Health, Environment and Training': Guidance on conduct of physical exertion in hot and humid climates.

Medical journal, Armed Forces India·2018
Same author

The Dietetic Value of Sago.

The Indian medical gazette·2017
Same author

Revelations of an overt water contamination.

Medical journal, Armed Forces India·2017
Same author

Growth and biochemical characteristics of an indigenous freshwater microalga, Scenedesmus obtusus, cultivated in an airlift photobioreactor: effect of reactor hydrodynamics, light intensity, and photoperiod.

Bioprocess and biosystems engineering·2017
Same author

Indications and Outcome of Carotid Doppler Ultrasound An Ophthalmic Perspective.

European journal of ophthalmology·2017
Same journal

Neuroradiology Leads NIH Funding Among Clinician Diagnostic Radiologists: A 14-Year National Analysis.

AJNR. American journal of neuroradiology·2026
Same journal

Neutral Cervical Spine MRI is Not Enough: The Critical Role of Flexion Imaging in Hirayama disease in Pediatric Patients.

AJNR. American journal of neuroradiology·2026
Same journal

CT Evaluation of Osseous Trauma at the Craniocervical Junction: A Pattern-Based Overview.

AJNR. American journal of neuroradiology·2026
Same journal

Comprehensive Structural MRI Phenotyping in <i>Oligophrenin 1-</i>Related Disorder Reveals Characteristic Brain Malformations.

AJNR. American journal of neuroradiology·2026
Same journal

ASNR-ESNR White Paper on Sustainability in Neuroradiology.

AJNR. American journal of neuroradiology·2026
Same journal

Intracranial Atherosclerotic Disease Distribution Across Circle of Willis Segments: Insights from CREST-H.

AJNR. American journal of neuroradiology·2026
See all related articles

Related Experiment Video

Updated: Jun 16, 2026

High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids
06:25

High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids

Published on: June 14, 2021

Cetuximab (erbitux).

W Bou-Assaly1, S Mukherji

  • 1Department of Radiologyand, University of Michigan Health System, Ann Arbor, USA. Wessam@med.umich.edu

AJNR. American Journal of Neuroradiology
|February 20, 2010
PubMed
Summary
This summary is machine-generated.

Cetuximab, a monoclonal antibody, effectively treats head and neck and colorectal cancers. This review covers its action, uses, side effects, and economics, including a clinical case.

Related Experiment Videos

Last Updated: Jun 16, 2026

High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids
06:25

High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids

Published on: June 14, 2021

Area of Science:

  • Oncology
  • Immunotherapy
  • Pharmacology

Background:

  • Cetuximab is a chimeric monoclonal antibody targeting the epidermal growth factor receptor (EGFR).
  • It has demonstrated efficacy in treating specific cancer types, notably head and neck and colorectal cancers.
  • Understanding its comprehensive profile is crucial for clinical application.

Purpose of the Study:

  • To provide a comprehensive review of Cetuximab.
  • To elucidate its mechanism of action, clinical indications, and adverse effects.
  • To discuss the economic considerations and present a relevant clinical case.

Main Methods:

  • Literature review of Cetuximab's mechanism, indications, and side effects.
  • Analysis of economic data related to Cetuximab therapy.
  • Presentation of a clinical case from the institution.

Main Results:

  • Cetuximab's mechanism involves EGFR inhibition, crucial for cancer cell proliferation.
  • Established indications include specific head and neck and colorectal cancers.
  • Common side effects and economic factors were detailed.

Conclusions:

  • Cetuximab is a valuable therapeutic option for indicated cancers.
  • A thorough understanding of its benefits, risks, and costs is essential for optimal patient management.
  • The clinical case illustrates practical application and considerations.